No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
-
Validation Study
MeSH terms
-
Adolescent
-
Adult
-
Aged
-
Aged, 80 and over
-
Antineoplastic Agents / therapeutic use*
-
Asian People / genetics
-
Bcl-2-Like Protein 11 / genetics*
-
Biomarkers, Tumor / genetics*
-
Female
-
Humans
-
Imatinib Mesylate / therapeutic use*
-
Kaplan-Meier Estimate
-
Leukemia, Myeloid, Chronic-Phase / drug therapy*
-
Leukemia, Myeloid, Chronic-Phase / genetics
-
Leukemia, Myeloid, Chronic-Phase / mortality
-
Male
-
Middle Aged
-
Polymorphism, Genetic
-
Predictive Value of Tests
-
Prognosis
-
Sequence Deletion
-
Treatment Outcome
-
Young Adult
Substances
-
Antineoplastic Agents
-
BCL2L11 protein, human
-
Bcl-2-Like Protein 11
-
Biomarkers, Tumor
-
Imatinib Mesylate